← Eichor
Condition: Invasive Ductal Carcinoma Breast Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Invasive Ductal Carcinoma Breast

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer
Phase 4 · 34 location(s) · Fudan University · NCT04790305A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07483307Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagn
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02918474Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer
NA · 1 location(s) · Istanbul Training and Research Hospital · NCT07003009Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer
Phase 2 · 1 location(s) · Yonsei University · NCT06677944Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)
NA · 22 location(s) · National Institute of Oncology, Hungary · NCT07067437Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)
Phase N/A · 2 location(s) · RPCR, Inc. · NCT04985032Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer
Phase 2 · 2 location(s) · Universität Münster · NCT06540872Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NA · 1 location(s) · Thomas Jefferson University · NCT04959474Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoi
Phase N/A · 4 location(s) · M.D. Anderson Cancer Center · NCT04169542Neoadjuvant Breast Cancer Time Restricted Eating
NA · 1 location(s) · Thomas Jefferson University · NCT05327608Radiation After No Axillary Nodal Sampling
NA · 1 location(s) · NYU Langone Health · NCT07723209[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 2 · 6 location(s) · Blue Earth Diagnostics · NCT07702292A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconst
NA · 1 location(s) · University of Florida · NCT06903468IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Phase N/A · 1 location(s) · Mount Carmel Health System · NCT03536897Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
NA · 1 location(s) · Glendale Adventist Medical Center d/b/a Adventist Health Gle · NCT05218044Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3 · 1 location(s) · RenJi Hospital · NCT03201861Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer
NA · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07507890Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer
Phase N/A · 1 location(s) · Istituto Oncologico Veneto IRCCS · NCT07613151Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Phase 2 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT04084730Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · 10 location(s) · ITM Oncologics GmbH · NCT057061295 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
Phase 2 · 1 location(s) · University of Utah · NCT06961955[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Phase 1 · 1 location(s) · University of California, Davis · NCT07020806[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Phase 1/Phase 2 · 1 location(s) · Blue Earth Diagnostics · NCT07432633Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
NA · 1 location(s) · HeroSupport SA · NCT07711847Biomarkers to Detect Endocrine Therapy Resistance
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06067503Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Phase 2 · 5 location(s) · Vanderbilt-Ingram Cancer Center · NCT05919108
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.